7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%

MAXIMUS, Inc.

by Todd Bunton

February 15, 2011 | Comments : 0 Recommended this article: (0)
MMS

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

MAXIMUS, Inc. ( MMS - Snapshot Report ) recently reported fourth quarter EPS of 99 cents, beating the Zacks Consensus Estimate by 3 cents. Analysts' estimates moved higher off the strong quarter, sending the stock to a Zacks #2 Rank (Buy). Based on the Zacks Consensus Estimate, analysts are expecting solid 13% EPS growth in both 2011 and 2012.

The company has also been returning value to shareholders in the form of stock buybacks and a dividend increase. Valuation is reasonable, too, with shares trading at 17.4x forward earnings, below the industry average.

Company Description

MAXIMUS, Inc. provides government services and health and human services program management and consulting services to its clients. It has more than 220 offices in the United States, Canada, Australia, and the United Kingdom.

Fourth Quarter Results

MAXIMUM reported its results for the fourth quarter on February 3. Revenue was up 5.3% year-over-year driven by the international employment services businesses in Australia and the United Kingdom in the Human Services Segment.

The gross margin expanded from 25.7% of sales to 26.1%. Earnings per share came in at 99 cents, beating the Zacks Consensus Estimate by 3 cents. It was a 14% increase over the same quarter in 2009.

Outlook

Management reiterated its guidance for 2011 following Q4 results. The company expects to earn $3.95 to $4.15 per share in 2011. The Zacks Consensus Estimate within guidance at $4.09, representing 13% growth over 2010 estimates.

The 2012 consensus estimate is also 13% higher at $4.63. It is a Zacks #2 Rank (Buy) stock.

Returning Value to Shareholders

The company spent $8.4 million to purchase 136,153 shares of common stock in the quarter. As of December 31, 2010, MAXIMUS had $118.6 million available under its current repurchase program.

The company also recently raised its quarterly dividend 25% from 12 cents per share to 15 cents. This marks just the second dividend hike since the company began paying a dividend in 2005. It currently yields 0.9%.

Valuation

The stock is up over 30% since September 1:

MMS: MAXIMUS, Inc.

Shares trade at 17.4x forward earnings, a discount to the industry average of 19.0x. Its price to sales ratio of 1.4 is in-line with its peers.

Todd Bunton is the Growth & Income Stock Strategist for Zacks.com.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.